Zelira Therapeutics Limited
ZLDAF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $1 | $0 | $3 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | -$0 | $0 |
| Inventory | $0 | $1 | $2 | $2 |
| Other Curr. Assets | $0 | $2 | $0 | $0 |
| Total Curr. Assets | $1 | $4 | $2 | $5 |
| Property Plant & Equip (Net) | $0 | $0 | $1 | $1 |
| Goodwill | $0 | $0 | $31 | $31 |
| Intangibles | $1 | $1 | $32 | $32 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $1 | $2 |
| Other NC Assets | $0 | $0 | -$32 | -$33 |
| Total NC Assets | $1 | $1 | $32 | $33 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1 | $5 | $34 | $38 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $2 | $2 |
| Short-Term Debt | $2 | $4 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $0 | $0 |
| Total Curr. Liab. | $6 | $7 | $2 | $2 |
| LT Debt | $0 | $2 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $2 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $1 |
| Total Liabilities | $6 | $9 | $2 | $2 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $46 | $46 | $46 | $44 |
| Retained Earnings | -$85 | -$81 | -$45 | -$39 |
| AOCI | $35 | $31 | $31 | $31 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$4 | -$5 | $32 | $35 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | -$0 | $0 |
| Total Liab. & Tot. Equity | $1 | $5 | $34 | $38 |
| Net Debt | $2 | $5 | $0 | -$2 |